PlainPill

MK-677 vs TB-500 for recovery

Short answer: For recovery, users rate them about the same: 99% report improvement with MK-677 (106 reports) and 96% with TB-500 (297 reports).

MK-677 has 0 meta-analyses and 15 randomized trials on PubMed; TB-500 has 0 and 3.

Based on 978 reports about MK-677 and 874 about TB-500. Not medical advice.

MK-677
Substance
TB-500
Peptide
Users say it helped39%helped479 reports · high confidence65%helped402 reports · high confidence
Verdict
Mixed
Mostly positive
ResearchBResearch: ModerateCResearch: Limited
Meta-analyses / RCTs0 / 150 / 3
Mainly used for
Recovery
% reporting improvement
99% (106)96% (297)
Appetite
% reporting improvement
66% (228)100% (2)
Pain & inflammation
% reporting improvement
68% (22)86% (199)
Sleep
% reporting improvement
79% (170)71% (7)
Performance
% reporting improvement
90% (87)96% (26)
Common side effectswater retention, fatigue, stomach issues, hungeranxiety, fatigue, dizziness, allergic reaction
Typical dose reported12.5 mg / before dinnerNot listed
MK-677
What a user said
“From my own experience (also have suffered from poor sleep), i experienced a noticeable increase in sleep quality even with a low dose.”
Full MK-677 profile →
TB-500
What a user said
“They reduce neuroinflammation in the brain caused by either head injuries or drug abuse. Ive used them both for this and it works.”
Full TB-500 profile →

Related comparisons

Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate